About Virologie - Hôpital NECKER
Clinical Trials at Virologie - Hôpital NECKER
During the past decade, Virologie - Hôpital NECKER conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Virologie - Hôpital NECKER
According to Clinical.Site data, the most researched conditions in "Virologie - Hôpital NECKER" are
"Cytomegalovirus" (1 trials) and "Transplant Recipients With CMV Infection" (1 trials). Many other conditions were trialed in "Virologie - Hôpital NECKER" in a lesser frequency.
Clinical Trials Intervention Types at Virologie - Hôpital NECKER
Most popular intervention types in "Virologie - Hôpital NECKER" are "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "CMV Infection" (1 trials) and "depistage" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Virologie - Hôpital NECKER
The vast majority of trials in "Virologie - Hôpital NECKER" are
2 trials for "All" genders.
Clinical Trials Status at Virologie - Hôpital NECKER
Currently, there are NaN active trials in "Virologie - Hôpital NECKER".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Virologie - Hôpital NECKER,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Virologie - Hôpital NECKER, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".